🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT03668327
Recruiting Observational

Preterm Birth Cohort Study in Guangzhou

NCT03668327 · tracked via the Priya Life Science China tracker
Sponsor
Guangzhou Women and Children's Medical Center
Phase
Observational
Started
2012-02-01
Last updated
2024-02-26

Condition(s) studied

Preterm BirthNeurodevelopmentImmune DevelopmentHost and Microbiome

Study summary

The Preterm Birth Cohort Study in Guangzhou (PBCSG) aims to explore the impact of genetic and environmental factors including life styles on preterm birth, to examine the interaction effect between these factors, and to follow up the short-term and long-term outcomes of preterm childrens.

Eligibility

Sex
ALL
Min age
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Born before 37 weeks of gestation 2. Born in Guangzhou Women and Children's Medical Center 3. Intended to remain in Guangzhou for more than 3 years Exclusion Criteria: 1. Multiple birth 2. Stillbirth 3. With major congenital abnormalities

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Guangzhou Women and Children's Medical Center, China Guangzhou China Recruiting

More Guangzhou Women and Children's Medical Center trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03668327 on ClinicalTrials.gov ↗ ← All trials in China